Next Level Wound Care

Created to Improve Lives

Every year, 5 million people in Germany suffer from extensive, chronic wounds such as diabetic foot syndrome, bedsores, leg ulcerations, as well as fungal infections and superinfections like those caused by severe burns. Patients‘ quality of life is heavily impacted as the healing process of these wounds is time-consuming, painful and expensive.

Driven by our passion to provide a new quality of life for those affected, we have invented and patented an innovative and effective treatment approach for wounds. Our specialists developed the Plasma- or CPTpatch, an active wound dressing that effectively treats wounds.

As the first company worldwide that uses the patented Active Glow technology, we enable a groundbreaking application that even combats multidrug resistance germs – without pain, covering large areas, quick and secure.

Wound infections – especially those caused by multi-resistant germs – are one of the most common complications for general wound healing, acute (burn) wounds as well as surgeries.

0 Million
Patients
0 Billion €
Treatment Costs Related to Infections
0 Billion €
Treatment Costs Associated with Chronic Wounds

At a Glance

0
Awards & Prizes
0Years
Development
0 +
Scientific Publications & Studies

Award-winning innovation

Due to the significant contribution of our CPTpatch to profoundly improve the lives of patients, we received more than 20 awards and prizes in the past, including the prestigious German Innovation Award in 2018.

.

Leading technology

Based on over 6 years of application-oriented research and development, we created a new way of treating wounds. The essence of our worldwide unique and patented Active Glow technology is cold plasma. Numerous studies have confirmed the positive effect of cold plasma on healing wounds and killing even multi-resistant germs.

Fast and without pain

The treatment with our active wound dressing takes only 2 minutes and is absolutely painfree. Initial results can often be seen after just a few days of treatment. The effects of cold plasma enables a lasting care for the damaged tissue.

Clinically proven

The outstanding effect and the safety of cold plasma have been confirmed in numerous studies and scientific publications.

Click here to view the studies

Easy to use

The CPTpatch was designed to meet the needs of patients and users. As a convenient and non-invasive treatment, it can be delegated and is even suitable for home care use in future.

Added value to healthcare

By using our technology, the costs of thousands of wound dressings, treatments and complication rates due to infections with multi-resistant bacteria can be dramatically reduced. This significantly eases the burden upon the healthcare system while increasing patient well-being.

Reimbursement

Compared to traditional and other modern wound therapies, wounds can be better treated using our CPTpatches. Even infections caused by multi-resistant pathogens are treated locally. The health care system (both outpatient and clinical) thus realizes enormous savings and therefore health insurance companies can cover the cost of treatment.

.

Product

The CPTpatch is a disposable, sterile, active wound dressing. CPTpatches are exclusively used in combination with the energy supply unit CPTcube. The CPTpatch has an atraumatic, self-adhesive border for an easy attachment to the area of application. During treatment, a physical plasma in the form of a purple glowing discharge is generated between the wound and the patient side of the CPTpatch.

The plasma converts the air within the defined volume between the CPTpatch and the wound surface into a physicallly active state. This is associated with the generation of alternating electric fields, light in the UV and infrared range, the formation of ions, and a slight increase in temperature. These components have an impact both on the whole skin-surface covered and in small pores, as well as skin depressions. The combination of these physical mechanisms results in an antimicrobial/antifungal effect of the physical plasma and stimulation of wound healing.

Any Questions?

Click here to find all the relevant information.

Patients

Indication | Treatment procedure

Read more

Physicians

Treatment instructions | Effects | Studies | Tolerability

Read more

Clinics/health insurance companies

Reimbursement
Read more

About us

COLDPLASMATECH emerged as a spin-off out of the Leibniz Institute for Plasma Science and Technology e.V. in Greifswald, Germany.

The interdisciplinary team surrounding Tobias Güra and Dr. Carsten Mahrenholz combines scientific skills and technical know-how at the highest level.

Contact us!

Dr. Carsten Mahrenholz
Dr. Carsten MahrenholzFounder / CEO
Biology / Chemistry / Economics
Tobias Güra
Tobias GüraFounder / COO
Medicine / Economics / Reimbursement
Greifswald Business Award, University Club
Leibniz Gründerpreis, Leibniz Gemeinschaft
Abgeordneter, YL Gesundheitsparlament

News

  • All
  • Informationen
  • Medien
  • Preise
  • Uncategorized

Network

Supporters

Media

Network

Contact

Got any questions?

Reach us by phone at +49 3834 7714700 or send us a message via our contact form.

We will get back to you immediately!